WallStSmart
NVCT

Nuvectis Pharma Inc

NASDAQ: NVCT · HEALTHCARE · BIOTECHNOLOGY

$10.00
+2.99% today

Updated 2026-05-06

Market cap
$268.66M
P/E ratio
P/S ratio
EPS (TTM)
$-1.31
Dividend yield
52W range
$6 – $11
Volume
0.1M

Nuvectis Pharma Inc (NVCT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-30.5%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+11.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-11.2%
2025-11-04
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$-0.31-22.0%$9.08$9.33+2.8%
2025-11-04$-0.44-76.0%$6.36$5.65-11.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.25$-0.31-22.0%
2025-09-30$-0.25$-0.44-76.0%
2025-06-30$-0.25$-0.30-20.0%
2025-03-31$-0.26$-0.27-3.8%
2024-12-31$-0.26$-0.35-36.3%$26.80M-753.4%
2024-09-30$-0.25$-0.24+4.0%
2024-06-30$-0.26$-0.26-0.8%
2024-03-31$-0.40$-0.25+37.5%
2023-12-31$-0.36$-0.41-13.9%$-4.10M
2023-09-30$-0.34$-0.37-8.8%
2023-06-30$-0.29$-0.38-31.0%
2023-03-31$-0.44$-0.27+38.6%$4.10M
2022-12-31$-0.38$-0.49-28.9%

Frequently asked questions

Has Nuvectis Pharma Inc beaten earnings estimates?
Nuvectis Pharma Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -30.5% over the last 4 quarters.
How does NVCT stock react to earnings?
NVCT stock has moved an average of -4.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.